Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2007
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/03/2007US20070099899 Heterocyclic dihydropyrimidine compounds
05/03/2007US20070098734 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma, insulin dependent diabetes, arthritis
05/03/2007US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer
05/03/2007DE102005047946A1 Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Behandlung von akuten und chronischen Lungenkrankheiten Use of activators of soluble guanylate cyclase for the treatment of acute and chronic lung diseases
05/03/2007CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient
05/03/2007CA2627485A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein
05/03/2007CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity
05/02/2007EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1778673A1 Novel hydantoin derivatives for the treatment of obstructive airway diseases
05/02/2007EP1778672A1 Crystalline form of a biphenyl compound
05/02/2007EP1778638A1 Diaryl ether beta2 adrenergic receptor agonists
05/02/2007EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2
05/02/2007EP1778230A2 Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
05/02/2007EP1778227A1 Inhalatory medicaments containing corticosteroids, betamimetic agents, and a novel anticholinergenic agent
05/02/2007EP1778226A1 Aerosol formulation for inhalation, containing an anticholinergenic agent
05/02/2007EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives
05/02/2007EP1526870B1 Combination of loteprednoletabonat and dfho for treating respiratory diseases, allergic diseases, asthma and copd
05/02/2007EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics
05/02/2007EP1441723B1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
05/02/2007EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof.
05/02/2007EP1341542B1 Indanylderivatives for treating airway diseases
05/02/2007EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
05/02/2007CN1956979A Thiazole derivative
05/02/2007CN1956978A [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase
05/02/2007CN1956728A Enzymes for pharmaceutical use
05/02/2007CN1956721A Quinazolinone derivatives useful as vanilloid antagonists
05/02/2007CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents
05/02/2007CN1954874A Curcuma zedoary oil fat injection and preparation process
05/02/2007CN1954871A Yanhouqing preparation for treating throat disease and its preparation method and quality control method
05/02/2007CN1954858A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954857A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954856A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954854A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954853A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954852A Chinese drugs compound preparation for treating asthma and its preparation method
05/02/2007CN1954851A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954850A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954842A Honey polygala root and its preparation method
05/02/2007CN1954841A Medicine for treating chronic pharyngitis
05/02/2007CN1954821A Traditional Chinese composite preparation for treating asthma and its preparation method
05/02/2007CN1954808A High dose Ambroxol hydrochloride freeze-dried preparation and preparation method
05/02/2007CN1954803A Spray-dried granules containing pranlukast and processes for the preparation thereof
05/02/2007CN1313469C Novel derivative of flavone c-glycoside and composition containing the same
05/02/2007CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof
05/02/2007CN1313450C Tachykinin receptor antagonists
05/02/2007CN1313448C Metalloproteinase inhibitors
05/02/2007CN1313153C Use of immunoglobulin and cell growth factor in preparing medicine for asthma
05/02/2007CN1313149C Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
05/02/2007CN1313142C Pharmaceutical composition with exterior syndrome easing, cough and asthma easing function
05/02/2007CN1313134C External-use traditional Chinese medicine for curing chronic rhinitis, nasosinusitis and laryngopharyngitis and its preparing method
05/02/2007CN1313116C Chinese traditional medicine for treating and preventing asthma in children
05/02/2007CN1313109C Decoction preparation of semen sinapis albae, fructus perillae and semen raphani and its preparing method
05/02/2007CN1313086C Aarin preparation for injection and preparing process thereof
05/01/2007US7211666 N-Cyclopropyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide; aminating with chloramine to produce a pyrrole with a Nitrogen nitrogen bond; reacting with formamide, cyclizing to form the pyrrolotriazine core; kinase inhibitors
05/01/2007US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics
05/01/2007US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
05/01/2007US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
05/01/2007US7211586 Substituted tetrahydroisoquinolines
05/01/2007US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity
05/01/2007US7211575 Methods of treating cytokine mediated diseases
05/01/2007US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia
05/01/2007US7211562 cytotoxic agents followed by a heat shock protein 90 inhibitor, has a synergistic effect on the growth inhibition of cells; destroying cells having a cell proliferative disorder with wild-type retinoblastoma gene
05/01/2007US7211261 Stable liquid formulations of botulinum toxin
05/01/2007US7211258 Protein A compositions and methods of use
05/01/2007US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders
05/01/2007CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2
05/01/2007CA2244357C A novel pharmaceutical composition for inhalation containing cr 2039 (andolast)
05/01/2007CA2226934C Ipratropium bromide enantiomer with a prolonged duration of action
04/2007
04/26/2007WO2007047576A1 Pharmacological treatments for sleep disorders
04/26/2007WO2007047575A2 Pharmacological treatments for sleep-related breathing disorders
04/26/2007WO2007046347A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
04/26/2007WO2007045980A1 Compositions of phosphodiesterase type iv inhibitors
04/26/2007WO2007045979A1 Pharmaceutical compositions of muscarinic receptor antagonists
04/26/2007WO2007045389A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma
04/26/2007WO2007045151A1 Compounds and their pharmaceutical compositions for the treatment of nasal cavum hypersecretion and chronic obstructive pulmonary disease
04/26/2007WO2007045046A1 Treatment of hypersensitivity
04/26/2007WO2006128847A3 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
04/26/2007WO2006128600A3 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
04/26/2007WO2006117300A3 Crystalline forms of tiotropium bromide
04/26/2007WO2006108039A3 Substituted azetidinones
04/26/2007WO2006067165A3 Indolidone derivatives for the treatment or prevention of fibrotic diseases
04/26/2007WO2006066234A3 Compositions and methods for reducing lung volume
04/26/2007US20070093553 HMB compositions and uses thereof
04/26/2007US20070093531 Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
04/26/2007US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies
04/26/2007US20070093510 Phosphodiesterase 4 inhibitors
04/26/2007US20070093491 Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases
04/26/2007US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin
04/26/2007US20070093416 Human beta-defensin secretion promoter
04/26/2007US20070092523 Combination Therapy Of Respiratory Diseases Using Antibodies
04/26/2007CA2626692A1 Treatment of hypersensitivity
04/26/2007CA2626628A1 Compositions of phosphodiesterase type iv inhibitors
04/26/2007CA2626612A1 Pharmaceutical compositions of muscarinic receptor antagonists
04/26/2007CA2625341A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
04/25/2007EP1777223A1 Indole derivatives useful as histamine H3 antagonists
04/25/2007EP1776962A1 Vaccine
04/25/2007EP1776959A2 Use of HGF for the manufacture of a medicament for treating fibrotic disorders
04/25/2007EP1776336A2 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them